Ralph O. Wallerstein

1.5k total citations
49 papers, 1.1k citations indexed

About

Ralph O. Wallerstein is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Ralph O. Wallerstein has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 19 papers in Genetics and 10 papers in Oncology. Recurrent topics in Ralph O. Wallerstein's work include Hemoglobinopathies and Related Disorders (16 papers), Iron Metabolism and Disorders (10 papers) and Erythrocyte Function and Pathophysiology (9 papers). Ralph O. Wallerstein is often cited by papers focused on Hemoglobinopathies and Related Disorders (16 papers), Iron Metabolism and Disorders (10 papers) and Erythrocyte Function and Pathophysiology (9 papers). Ralph O. Wallerstein collaborates with scholars based in United States, Belgium and Canada. Ralph O. Wallerstein's co-authors include Paul M. Aggeler, M. Silvija Hoag, Stanley L. Robbins, Parvin Saidi, Gary Spitzer, Myron Pollycove, Frank Dunphy, Jonathan C. Yau, Frankie A. Holmes and Aman U. Buzdar and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Ralph O. Wallerstein

46 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph O. Wallerstein United States 18 478 252 214 148 116 49 1.1k
Richard L. DeGowin United States 19 338 0.7× 176 0.7× 243 1.1× 139 0.9× 185 1.6× 45 1.0k
G. Perona Italy 27 320 0.7× 279 1.1× 329 1.5× 172 1.2× 118 1.0× 68 1.6k
R. M. Lowenthal Australia 20 501 1.0× 319 1.3× 268 1.3× 251 1.7× 73 0.6× 58 1.5k
Liberto Pechet United States 18 421 0.9× 77 0.3× 160 0.7× 153 1.0× 52 0.4× 66 1.1k
E. J. Freireich United States 22 712 1.5× 512 2.0× 266 1.2× 297 2.0× 139 1.2× 66 1.6k
R A Crockson United Kingdom 17 232 0.5× 130 0.5× 92 0.4× 212 1.4× 114 1.0× 24 1.2k
C. Merskey United States 21 1.2k 2.5× 83 0.3× 278 1.3× 159 1.1× 101 0.9× 54 2.2k
A. van den Ende Netherlands 16 301 0.6× 181 0.7× 58 0.3× 165 1.1× 93 0.8× 42 1.4k
James L. Tullis United States 19 316 0.7× 103 0.4× 84 0.4× 109 0.7× 113 1.0× 46 944
C Chatelain France 27 665 1.4× 202 0.8× 282 1.3× 426 2.9× 152 1.3× 170 2.6k

Countries citing papers authored by Ralph O. Wallerstein

Since Specialization
Citations

This map shows the geographic impact of Ralph O. Wallerstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph O. Wallerstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph O. Wallerstein more than expected).

Fields of papers citing papers by Ralph O. Wallerstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph O. Wallerstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph O. Wallerstein. The network helps show where Ralph O. Wallerstein may publish in the future.

Co-authorship network of co-authors of Ralph O. Wallerstein

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph O. Wallerstein. A scholar is included among the top collaborators of Ralph O. Wallerstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph O. Wallerstein. Ralph O. Wallerstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wallerstein, Ralph O., et al.. (2010). Six Year Old with Autoimmune Polyglandular Syndrome: Can Genetics Tell Us the Story?. Journal of Pediatric Endocrinology and Metabolism. 23(7). 725–8. 3 indexed citations
2.
Hester, Jeane P. & Ralph O. Wallerstein. (1993). Peripheral blood stem cell transplantation for breast cancer patients with bone marrow metastases using GM-CSF priming. Transfusion Science. 14(1). 65–69. 2 indexed citations
3.
Yau, Jonathan C., Meletios Α. Dimopoulos, S. Huan, et al.. (1991). Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantation. European Journal Of Haematology. 47(5). 371–376. 20 indexed citations
4.
Yau, Jonathan C., S. Huan, Meletios Α. Dimopoulos, et al.. (1991). An effective acute graft‐vs.‐host disease prophylaxis with minidose methotrexate, cyclosporine, and single‐dose methylprednisolone. American Journal of Hematology. 38(4). 288–292. 7 indexed citations
5.
Huan, S., Jonathan C. Yau, Frank Dunphy, et al.. (1991). Impact of autologous bone marrow infusion on hematopoietic recovery after high-dose cyclophosphamide, etoposide, and cisplatin.. Journal of Clinical Oncology. 9(9). 1609–1617. 16 indexed citations
6.
Wallerstein, Ralph O., Gary Spitzer, Frank Dunphy, et al.. (1990). A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer.. Journal of Clinical Oncology. 8(11). 1782–1788. 43 indexed citations
7.
Dunphy, Frank, Gary Spitzer, Aman U. Buzdar, et al.. (1990). Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support.. Journal of Clinical Oncology. 8(7). 1207–1216. 146 indexed citations
8.
Wallerstein, Ralph O.. (1977). Marrow Iron. JAMA. 238(15). 1661–1661. 1 indexed citations
9.
Lagios, Michael D., et al.. (1974). Atypical Azurophilic Crystals in Chronic Lymphocytic Leukemia: A Case Report and Comparison with Other Crystalline Inclusions. American Journal of Clinical Pathology. 62(3). 342–349. 12 indexed citations
10.
Fish, Mathews B., et al.. (1973). Simultaneous measurement of free and intrinsic factor (IF) bound vitamin B12 (B12) absorption; absolute quantitation with incomplete stool collection and rapid relative measurement using plasma B12 (IF): B12 absorption ratio.. PubMed. 14(8). 568–75. 4 indexed citations
11.
Fish, Mathews B., et al.. (1972). The oxidation of the beta carbon of serine in human folate and vitamin B 12 deficiency.. PubMed. 80(3). 395–404. 8 indexed citations
12.
Wallerstein, Ralph O.. (1971). Advances in Blood Grouping III.. Archives of Internal Medicine. 128(5). 837–837.
13.
Wallerstein, Ralph O.. (1969). Statewide Study of Chloramphenicol Therapy and Fatal Aplastic Anemia. JAMA. 208(11). 2045–2045. 191 indexed citations
14.
Wallerstein, Ralph O.. (1968). CLINICAL PROFILES. Blood. 32(4). 690–695. 15 indexed citations
15.
Kasper, Carol K. & Ralph O. Wallerstein. (1966). Red Cell Values in Healthy Adolescents. American Journal of Clinical Nutrition. 18(4). 286–293. 4 indexed citations
16.
Cohen, Richard J., et al.. (1966). Waldenström's macroglobulinemia. The American Journal of Medicine. 41(2). 274–284. 41 indexed citations
17.
Wallerstein, Ralph O., et al.. (1964). The Treatment of Iron-Deficiency Anemia with Intravenous Iron Dextran. Blood. 23(3). 354–358. 63 indexed citations
18.
Wallerstein, Ralph O.. (1957). TREATMENT WITH IRON-DEXTRAN OF IRON-DEFICIENCY ANEMIA IN CHILDREN. Journal of the American Medical Association. 164(9). 962–962. 6 indexed citations
19.
Wallerstein, Ralph O. & Paul M. Aggeler. (1956). Anemia, differentiating between thalassemia minor and iron deficiency.. PubMed. 84(3). 176–9. 5 indexed citations
20.
Wallerstein, Ralph O., John William Harris, Robert Schilling, & William B. Castle. (1953). Observations on the etiologic relationship of achylia gastrica to pernicious anemia. XV. Hematopoietic effects of simultaneous intravenous and of simultaneous or serial oral administration of intrinsic factor and vitamin B12.. PubMed. 41(3). 363–75. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard L. DeGowin Breakdown of academic impact, for papers by G. Perona Breakdown of academic impact, for papers by R. M. Lowenthal Breakdown of academic impact, for papers by Liberto Pechet Breakdown of academic impact, for papers by E. J. Freireich Breakdown of academic impact, for papers by R A Crockson Breakdown of academic impact, for papers by C. Merskey Breakdown of academic impact, for papers by A. van den Ende Breakdown of academic impact, for papers by James L. Tullis Breakdown of academic impact, for papers by C Chatelain
Rankless by CCL
2026